-
Indian Journal of Ophthalmology Oct 2016To determine the publication rates of free papers and posters presented at the All India Ophthalmic Conference (AIOC) 2010 in peer-reviewed journals up to December 2015... (Review)
Review
PURPOSE
To determine the publication rates of free papers and posters presented at the All India Ophthalmic Conference (AIOC) 2010 in peer-reviewed journals up to December 2015 and compare this with publication rates from AIOC2000 published previously.
METHODS
A thorough literature search was conducted using PubMed, Google Scholar, and the general Google search engine by two independent investigators. The title of the paper, keywords and author names were used to "match" the AIOC free-paper with the published paper. In addition, the "purpose," "methods," and "outcome measures" between the two were studied to determine the "match."
RESULTS
A total of 58 out of 394 free-papers (14.7%) from AIOC2010 were published till December 2015 compared to 16.5% from AIOC2000. Out of these, 52 (90%) were published in PubMed indexed journals. Maximum publications were seen in pediatric ophthalmology (50%) followed by glaucoma (24.4%) and cornea (23.8%). Fifteen out of 272 posters (5.5%) were published; orbit/oculoplastics had the highest poster publications (13%). Excluding papers in nonindexed journals and those by authors with international affiliations, the publication rate was approximately 12%.
CONCLUSION
The publication rate of free papers from AIOC2010 has marginally reduced compared to AIOC2000. Various causes for this such as lack of adequate training, motivation, and lack of incentives for research in the Indian scenario have been explored, and measures to improve this paradigm have been discussed. It will be prudent to repeat this exercise every decade to compare publication rates between periodic AIOC, stimulate young minds for quality research and educate policy makers toward the need for developing dedicated research departments across the country.
Topics: Biomedical Research; Congresses as Topic; Humans; India; Ophthalmology; Publications
PubMed: 27905332
DOI: 10.4103/0301-4738.195007 -
PloS One 2021Quantifying a society's value system is important because it suggests what people deeply care about-it reflects who they actually are and, more importantly, who they...
Quantifying a society's value system is important because it suggests what people deeply care about-it reflects who they actually are and, more importantly, who they will like to be. This cultural quantification has been typically done by studying literary production. However, a society's value system might well be implicitly quantified based on the decisions that people took in the past and that were mediated by what they care about. It turns out that one class of these decisions is visible in ordinary settings: it is visible in street names. We studied the names of 4,932 honorific streets in the cities of Paris, Vienna, London and New York. We chose these four cities because they were important centers of cultural influence for the Western world in the 20th century. We found that street names greatly reflect the extent to which a society is gender biased, which professions are considered elite ones, and the extent to which a city is influenced by the rest of the world. This way of quantifying a society's value system promises to inform new methodologies in Digital Humanities; makes it possible for municipalities to reflect on their past to inform their future; and informs the design of everyday's educational tools that promote historical awareness in a playful way.
Topics: Biodiversity; Cities; Culture; Female; Humans; London; Male; Names; New York; Occupations; Paris; Residence Characteristics; Sex Factors
PubMed: 34191817
DOI: 10.1371/journal.pone.0252869 -
BMJ Quality & Safety Jul 2016Efforts to ensure effective participation of patients in healthcare are called by many names-patient centredness, patient engagement, patient experience. Improvement...
Efforts to ensure effective participation of patients in healthcare are called by many names-patient centredness, patient engagement, patient experience. Improvement initiatives in this domain often resemble the efforts of manufacturers to engage consumers in designing and marketing products. Services, however, are fundamentally different than products; unlike goods, services are always 'coproduced'. Failure to recognise this unique character of a service and its implications may limit our success in partnering with patients to improve health care. We trace a partial history of the coproduction concept, present a model of healthcare service coproduction and explore its application as a design principle in three healthcare service delivery innovations. We use the principle to examine the roles, relationships and aims of this interdependent work. We explore the principle's implications and challenges for health professional development, for service delivery system design and for understanding and measuring benefit in healthcare services.
Topics: Delivery of Health Care; Humans; Models, Organizational; Patient Participation; Quality Assurance, Health Care; Quality Improvement
PubMed: 26376674
DOI: 10.1136/bmjqs-2015-004315 -
European Annals of Otorhinolaryngology,... Feb 2019
Topics: Abbreviations as Topic; Bibliometrics; Europe; France; Journal Impact Factor; Publishing; Science
PubMed: 30377059
DOI: 10.1016/j.anorl.2018.10.013 -
JAMA Health Forum May 2022New formulations of prescription drugs can improve convenience and tolerability for patients, but they also constitute manufacturer strategies to extend brand-name drug...
IMPORTANCE
New formulations of prescription drugs can improve convenience and tolerability for patients, but they also constitute manufacturer strategies to extend brand-name drug market exclusivity periods.
OBJECTIVE
To examine whether new formulations of brand-name novel drugs were associated with novel drugs' sales and/or therapeutic value, as well as characterize first new formulations' approval timing relative to the novel drug's generic approval.
DESIGN SETTING AND PARTICIPANTS
This cross-sectional study used the Drugs@FDA database to identify all novel tablet and capsule drugs approved by the US Food and Drug Administration (FDA) between 1995 and 2010 and followed through December 31, 2021.
EXPOSURES
Novel drugs' blockbuster status, defined as annual sales of $1 billion or greater, and therapeutic value, measured by (1) accelerated approval status, (2) World Health Organization Model Lists of Essential Medicines inclusion, (3) innovativeness, and (4) clinical usefulness.
MAIN OUTCOMES AND MEASURES
Approval of a new formulation and timing relative to a novel drug's first generic's approval.
RESULTS
Among the 206 novel drugs in tablet or capsule form approved by the FDA from 1995 to 2010, 81 (39.3%) were followed by an FDA-approved new formulation, and 167 (81.1%) had a generic version as of December 31, 2021. In multivariable analyses, new formulations were statistically significantly more likely among blockbuster drugs vs not (58.2% vs 27.6%; adjusted odds ratio [AOR], 4.72; 95% CI, 2.26-9.87; < .001) and those granted accelerated approval vs not (50.0% vs 37.6%; AOR, 5.48; 95% CI, 1.52-19.67; = .009), and less likely among orphan products vs not (11.8% vs 44.8%; AOR, 0.13; 95% CI, 0.03-0.52; = .004). Essential medicine listing vs no listing (47.8% vs 36.9%; AOR, 1.32; 95% CI, 0.52-3.34; = .56), first-in-class or advance-in-class status vs addition-to-class status (37.8% vs 40.5%; AOR, 0.71; 95% CI, 0.32-1.58; = .40), and categorization as clinically useful vs not useful (40.9% vs 44.8%; AOR, 0.81; 95% CI, 0.34-1.92; = .64) were not associated with increased likelihood of a new formulation. First new formulations were statistically significantly less likely to be approved after the novel drug's first generic approval (84.6% vs 15.4%; < .001).
CONCLUSIONS AND RELEVANCE
In this cross-sectional study of novel drugs in tablet or capsule form approved by the FDA between 1995 and 2010, manufacturers pursued new formulations of best-selling brand-name drugs and those granted accelerated approval but did so less frequently once generic competitors entered the market. Other measures of therapeutic value were not associated with new formulations.
Topics: Cross-Sectional Studies; Drug Approval; Drugs, Generic; Humans; Prescription Drugs; Tablets; United States; United States Food and Drug Administration
PubMed: 35977259
DOI: 10.1001/jamahealthforum.2022.1096 -
The Canadian Journal of Urology Jun 2014
Topics: Abbreviations as Topic; Clinical Trials as Topic; Humans; Names; Translational Research, Biomedical; United States; Urology
PubMed: 24978352
DOI: No ID Found -
Implementation Science : IS Feb 2020Application of knowledge translation (KT) theories, models, and frameworks (TMFs) is one method for successfully incorporating evidence into clinical care. However,...
BACKGROUND
Application of knowledge translation (KT) theories, models, and frameworks (TMFs) is one method for successfully incorporating evidence into clinical care. However, there are multiple KT TMFs and little guidance on which to select. This study sought to identify and describe available full-spectrum KT TMFs to subsequently guide users.
METHODS
A scoping review was completed. Articles were identified through searches within electronic databases, previous reviews, grey literature, and consultation with KT experts. Search terms included combinations of KT terms and theory-related terms. Included citations had to describe full-spectrum KT TMFs that had been applied or tested. Titles/abstracts and full-text articles were screened independently by two investigators. Each KT TMF was described by its characteristics including name, context, key components, how it was used, primary target audience, levels of use, and study outcomes. Each KT TMF was also categorized into theoretical approaches as process models, determinant frameworks, classic theories, implementation theories, and evaluation frameworks. Within each category, KT TMFs were compared and contrasted to identify similarities and unique characteristics.
RESULTS
Electronic searches yielded 7160 citations. Additional citations were identified from previous reviews (n = 41) and bibliographies of included full-text articles (n = 6). Thirty-six citations describing 36 full-spectrum were identified. In 24 KT TMFs, the primary target audience was multi-level including patients/public, professionals, organizational, and financial/regulatory. The majority of the KT TMFs were used within public health, followed by research (organizational, translation, health), or in multiple contexts. Twenty-six could be used at the individual, organization, or policy levels, five at the individual/organization levels, three at the individual level only, and two at the organizational/policy level. Categorization of the KT TMFs resulted in 18 process models, eight classic theories, three determinant frameworks, three evaluation frameworks, and four that fit more than one category. There were no KT TMFs that fit the implementation theory category. Within each category, similarities and unique characteristics emerged through comparison.
CONCLUSIONS
A systematic compilation of existing full-spectrum KT TMFs, categorization into different approaches, and comparison has been provided in a user-friendly way. This list provides options for users to select from when designing KT projects and interventions.
TRIAL REGISTRATION
A protocol outlining the methodology of this scoping review was developed and registered with PROSPERO (CRD42018088564).
Topics: Delivery of Health Care; Humans; Models, Organizational; Research Design; Translational Research, Biomedical
PubMed: 32059738
DOI: 10.1186/s13012-020-0964-5 -
Fertility and Sterility Jan 2022This committee opinion provides practitioners with suggestions for optimizing the likelihood of achieving pregnancy in couples or individuals attempting conception who...
This committee opinion provides practitioners with suggestions for optimizing the likelihood of achieving pregnancy in couples or individuals attempting conception who have no evidence of infertility. This document replaces the document of the same name previously published in 2013 (Fertil Steril 2013;100:631-7).
Topics: Adult; Directive Counseling; Endocrinologists; Feeding Behavior; Female; Fertility; Humans; Infant, Newborn; Infertility; Male; Pregnancy; Reproductive Medicine; Reproductive Techniques, Assisted; Risk Reduction Behavior; Societies, Medical; United States
PubMed: 34815068
DOI: 10.1016/j.fertnstert.2021.10.007 -
Ceska a Slovenska Oftalmologie :... 2022After the end of the First World War, the most important event in the history of our country was the establishment of the Czechoslovak Republic on October 28, 1918....
After the end of the First World War, the most important event in the history of our country was the establishment of the Czechoslovak Republic on October 28, 1918. Professor Deyl repeatedly spoke about the need to establish a Czechoslovak Ophthalmological Society. Only his successor, professor. O. Lešer implemented Deyl's idea and, in agreement with the heads of the Bratislava and Brno departments of ophthalmology, convened the opening general meeting of the Czechoslovak Ophthalmological Society on April 3, 1926, in the auditorium of the Czech department of ophthalmology with the participation of 37 ophthalmologists. Not all Czechoslovak ophthalmologists were present at this first meeting of the Czechoslovak Ophthalmological Society; their number can be estimated at about 55 in 1926. Immediately after the founding of the Czechoslovak Ophthalmological Society in 1926, a yearbook of congress works began to be published in the same year, every year until 1932, a total of 7 volumes. By the decision of the General Meeting of the Czechoslovak Ophthalmological Society, held on 15 May 1933, the publication of congress works was built on a new basis. The current form of the collection was abandoned, and the periodical journal Czechoslovak Ophthalmology was founded. In 1954, the Slovak branch of the ophthalmological section of the Czechoslovak Ophthalmological Society was founded, which quickly developed its activities and twice a year organized very successful and scientifically valuable congresses with rich participation and discussion. The name of the organization "Slovak branch of the Ophthalmological Section of the Czechoslovak Medical Society of J. E. Purkyně" was chosen. In 1969, under the Federalization Act, medical societies were reorganized; the Czech and Slovak Ophthalmological Society is established. The Federal Committee has since consisted of the chairs and secretaries of the two National Committees, who took turns in the leadership of the Federal Committee during their term of office. After the division of Czechoslovakia in 1993, the name of the magazine changed. Until 1994 it was published under the name Czechoslovak Ophthalmology and since 1995 the name has been changed to Czech and Slovak Ophthalmology. The first issue was published in February 1995, the continuity of the journal and the numbering has been preserved.
Topics: Anniversaries and Special Events; Humans; Ophthalmologists; Ophthalmology; Slovakia; Societies, Medical
PubMed: 35300498
DOI: 10.31348/2022/3 -
ELife Jul 2020Some acronyms are useful and are widely understood, but many of the acronyms used in scientific papers hinder understanding and contribute to the increasing...
Some acronyms are useful and are widely understood, but many of the acronyms used in scientific papers hinder understanding and contribute to the increasing fragmentation of science. Here we report the results of an analysis of more than 24 million article titles and 18 million article abstracts published between 1950 and 2019. There was at least one acronym in 19% of the titles and 73% of the abstracts. Acronym use has also increased over time, but the re-use of acronyms has declined. We found that from more than one million unique acronyms in our data, just over 2,000 (0.2%) were used regularly, and most acronyms (79%) appeared fewer than 10 times. Acronyms are not the biggest current problem in science communication, but reducing their use is a simple change that would help readers and potentially increase the value of science.
Topics: Abbreviations as Topic; Editorial Policies; Literature; Periodicals as Topic; Publishing
PubMed: 32701448
DOI: 10.7554/eLife.60080